Harvard Bioscience (HBIO) vs Milestone Scientific (MLSS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Harvard Bioscience (HBIO) has outperformed Milestone Scientific (MLSS) over the past year, gaining 84.8% versus a loss of 23.4%. Over five years, MLSS leads with a -82.9% price change compared with -88.1% for HBIO. Harvard Bioscience is the larger company by market cap ($37.7 million vs $32.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HBIO | MLSS |
|---|---|---|
| Share price | $8.29 | $0.36 |
| Market cap | $37.74M | $32.62M |
| 1-day change | +1.94% | 0.00% |
| YTD return | +21.34% | +33.33% |
| 1-year return | +84.77% | -23.40% |
| 5-year return | -88.11% | -82.94% |
| Forward P/E | 12.85 | — |
| EPS (TTM) | $-2.31 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.40 | $0.58 |
| 52-week low | $3.80 | $0.22 |
| Distance from 52-week high | -11.81% | -37.93% |
| Analyst consensus | none | none |
| Avg. price target upside | -9.53% | +247.22% |
| Average volume | 17.98K | 128.06K |
| Shares outstanding | 4.55M | 90.61M |
| Employees | 316 | 15 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HBIO has outperformed MLSS by 108.2 percentage points over the past year.
- The two companies sit in different sectors: Harvard Bioscience in Industrials and Milestone Scientific in Health Care.
About Harvard Bioscience
HBIO stock →Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 316 employees
About Milestone Scientific
MLSS stock →Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments.
Health Care · Industrial Specialties · 15 employees
HBIO vs MLSS FAQ
Which is bigger, Harvard Bioscience or Milestone Scientific?
Harvard Bioscience (HBIO) is larger, with a market capitalization of $37.74M compared with $32.62M for Milestone Scientific (MLSS).
Which stock has performed better over the past year, HBIO or MLSS?
HBIO returned +84.77% over the past 12 months, compared with -23.40% for MLSS (price return, excluding dividends). Past performance does not predict future results.
Are Harvard Bioscience and Milestone Scientific in the same industry?
No. Harvard Bioscience is in the Industrials sector, while Milestone Scientific is in Health Care.